Clinical Trial Update: Intra-arterial Microplasmin Administration in Patients With Acute Intracranial Vertebrobasilar Artery Occlusion [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intra-arterial microplasmin (Cethrin) for acute ischemic vertebrobasilar artery occlusion has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Cethrin

Snippet

Sponsor: ThromboGenics | Conditions: Stroke | Phase 2 | Status: TERMINATED